Seqens – API Manufacturing Capabilities

PCI is a fully integrated Active Pharmaceutical Ingredient (API) manufacturer and custom synthesis supplier. We’ll be with you every step of the way as you develop your final API or chemical product.

Posted: April 6, 2017

Author:
Tags: API Manufacturing | Video
API Manufacturing and Pharmaceutical Manufacturing

 

Related posts:

How to Select a CMO
Growth of targeted therapies gives rise to need for flexible manufacturing of smaller API quantities
Providing Incentives to Attract Life Science Leaders to the State is Half the Battle
When Does it Makes Sense for CDMOs to Collaborate?
4 Questions to Ask Prospective CMOs about Reaction Technologies

About the Author

Ed Price CEO of PCI Synthesis
Ed is President & CEO of SEQENS North America (formerly PCI Synthesis). He serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA)...

Do you have questions? Talk to Ed.